|
09 Apr 2025 |
Sheela Foam
|
Consensus Share Price Target
|
683.40 |
1030.00 |
- |
50.72 |
hold
|
|
|
|
|
06 Aug 2024
|
Sheela Foam
|
Keynote Capitals Ltd
|
683.40
|
885.00
|
951.95
(-28.21%)
|
Target met |
Sell
|
|
|
Quarterly Update Q1FY25
|
|
24 May 2024
|
Sheela Foam
|
Keynote Capitals Ltd
|
683.40
|
865.00
|
905.90
(-24.56%)
|
Target met |
Sell
|
|
|
Quarterly Update Q4FY24
|
|
22 May 2024
|
Sheela Foam
|
ICICI Securities Limited
|
683.40
|
1150.00
|
922.70
(-25.93%)
|
68.28 |
Buy
|
|
|
Consol. revenue (organic) performance (-10% YoY) was dragged by a continued decline in its B2B businesses (led by price corrections). Positively, branded mattress volumes are growing well with accelerated growth in Sleepwell (+31% YoY) and Kurl on (+17% YoY) driven by launches and TVC campaigns.
|
|
08 Feb 2024
|
Sheela Foam
|
Keynote Capitals Ltd
|
683.40
|
|
1127.20
(-39.37%)
|
|
Not Rated
|
|
|
Quarterly Update Q3FY24
|
|
06 Nov 2023
|
Sheela Foam
|
Keynote Capitals Ltd
|
683.40
|
|
1080.80
(-36.77%)
|
|
Results Update
|
|
|
Quarterly Update Q2FY24
|
|
07 Aug 2023
|
Sheela Foam
|
Keynote Capitals Ltd
|
683.40
|
|
1153.85
(-40.77%)
|
|
Not Rated
|
|
|
Quarterly Update Q1FY24
|
|
20 Jul 2023
|
Sheela Foam
|
Keynote Capitals Ltd
|
683.40
|
|
1212.65
(-43.64%)
|
|
Not Rated
|
|
|
Company Update
|
|
18 Jul 2023
|
Sheela Foam
|
ICICI Securities Limited
|
683.40
|
1400.00
|
1236.90
(-44.75%)
|
|
Buy
|
|
|
Acquisition of Kurlon is positive for the stakeholders of Sheela Foam: (1) SHEELA’s market share in South and East India has room for improvement (vs North and West India where it enjoys ~40% market share).
|
|
12 Jun 2023
|
Sheela Foam
|
Keynote Capitals Ltd
|
683.40
|
1311.00
|
1154.50
(-40.81%)
|
Target met |
Buy
|
|
|
Initiating Coverage Report
|
|
19 May 2023
|
Sheela Foam
|
ICICI Direct
|
683.40
|
1280.00
|
1044.40
(-34.57%)
|
Target met |
Buy
|
|
|
|
|
19 May 2023
|
Sheela Foam
|
ICICI Securities Limited
|
683.40
|
1300.00
|
1044.40
(-34.57%)
|
Target met |
Buy
|
|
|
Revenue print continues to be weak, down 1% YoY. India branded business’ volume decline of 21% YoY was weak driven by significant decline in footfalls. Steps are being taken to drive footfalls by increasing footprint of EBOs (20% YoY) and planned new campaign for Sleepwell brand in FY24.
|
|
21 Dec 2022
|
Sheela Foam
|
ICICI Direct
|
683.40
|
1650.00
|
1275.05
(-46.40%)
|
Pre-Bonus/
Split |
Buy
|
|
|
|
|
03 Dec 2022
|
Sheela Foam
|
ICICI Direct
|
683.40
|
3300.00
|
2626.85
(-73.98%)
|
Pre-Bonus/
Split |
Buy
|
|
|
|
|
09 Nov 2022
|
Sheela Foam
|
ICICI Securities Limited
|
683.40
|
3400.00
|
2829.70
(-75.85%)
|
Pre-Bonus/
Split |
Buy
|
|
|
2QFY23: Revenue print further weakened, down 8% YoY. India braded business’
16% YoY revenue decline (volumes down 18% YoY) was quite weak with it highlighting a softer demand environment.
|
|
20 Sep 2022
|
Sheela Foam
|
ICICI Direct
|
683.40
|
3650.00
|
2891.95
(-76.37%)
|
Pre-Bonus/
Split |
Buy
|
|
|
|
|
24 Jun 2022
|
Sheela Foam
|
ICICI Direct
|
683.40
|
|
2679.55
(-74.50%)
|
Pre-Bonus/
Split |
Not Rated
|
|
|
|
|
19 Jan 2021
|
Sheela Foam
|
Axis Direct
|
683.40
|
2140.00
|
2027.85
(-66.30%)
|
Target met |
Buy
|
|
|
We recommend a BUY on Sheela Foam with a Target Price of Rs 2,140, an upside of ~9% from CMP of Rs. 1,964 and Stop Loss Rs1,876.
|
|
23 Nov 2020
|
Sheela Foam
|
Rudra Shares and Stock Brokers Ltd
|
683.40
|
1650.00
|
1531.85
(-55.39%)
|
Target met |
Buy
|
|
|
Company being top player in the mattress and foam products industry in India with estimated market share of 20-23% in the organized market. Its best-known brand Sleep well has been fortified by the revolutionary health-boosting technology Neem Fresche. Furthermore, company expected to be...
|
|
17 Feb 2020
|
Sheela Foam
|
Axis Direct
|
683.40
|
1643.00
|
1639.20
(-58.31%)
|
Target met |
Hold
|
|
|
In Q3FY20, Sheela foam Ltd. reported sales revenues of Rs 658 cr (up 15%YoY& 32% QoQ), EBIDTA of Rs 93.8 cr grew strongly by 54% YoY& 33% QoQ. EBIDTA margin improved to 14.3% up 360 bps YoY& flattish QoQ.
|
|
05 Dec 2019
|
Sheela Foam
|
Axis Direct
|
683.40
|
1553.00
|
1322.30
(-48.32%)
|
Target met |
Buy
|
|
|
In Q2FY20, Sheela foam Ltd. reported sales revenues of Rs 497 cr (down 7%YoY& down 3%QoQ), EBIDTA of Rs 70 cr grew strongly by 66% YoY& 13% QoQ. EBIDTA margin improved to 14.2% up 625 bps YoY& 210 bps QoQ. Profit of Rs 59 cr was up 2.4x on yearly basis and 1.5x quarterly basis.
|